Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| ADMA BioManufacturing | | | | 22.2 | 6.8 | 11.0 | | |
| Plasma Collection Centers | | | | 7.0 | 10.0 | 11.6 | 10.5 | 7.1 |
| Corporate | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Consolidated (member) | | | | 29.3 | | | | |
| |
| EBITDA |
| ADMA BioManufacturing | | | | -26.6 | -43.0 | -17.6 | | |
| Plasma Collection Centers | | | | -0.9 | -3.7 | -1.7 | -0.9 | -1.5 |
| Corporate | -22.3 | -17.0 | -13.6 | -10.7 | -10.2 | -17.3 | -16.0 | -6.6 |
| Research And Development | | | | | | | | -7.0 |
| Consolidated (member) | | | | -38.2 | | | | |
| |
| EBIT |
| ADMA BioManufacturing | | | | -29.4 | -45.6 | -19.8 | | |
| Plasma Collection Centers | | | | -1.3 | -4.5 | -2.2 | -1.3 | -1.9 |
| Corporate | -22.3 | -17.0 | -13.6 | -10.7 | -10.2 | -17.3 | -16.0 | -6.6 |
| Research And Development | | | | | | | | -7.0 |
| Consolidated (member) | | | | -41.4 | | | | |
| |
| Mix |
| ADMA BioManufacturing | | | | 75.6% | 40.0% | 48.2% | | |
| Plasma Collection Centers | | | | 24.0% | 59.1% | 51.1% | 98.7% | 98.2% |
| Corporate | 0.1% | 0.2% | 0.3% | 0.5% | 0.8% | 0.6% | 1.3% | 1.8% |
| Consolidated (member) | | | | 100.0% | | | | |
| |
| Growth |
| ADMA BioManufacturing | | | | 226.2% | -38.1% | | | |
| Plasma Collection Centers | | | | -30.0% | -13.7% | 10.6% | 49.2% | 20.7% |
| Corporate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 12.2% | 68.6% |
|